Text

nalisis Respon Terapi Antiretroviral pada Pasien HIV/AIDS (Response to Antiretroviral Therapy Undergone by HIV/AIDS patients)

---

HIV/AIDS, with new cases there of coming up year after year, is a fast , is a fast-growing disease. In order to inhibit HIV replication, ARV is administered to HIV/AIDS patients throughout his life-time. Continous monitoring for thhe detection of its desired result to be conducted. This study is aimed to find out the respone of ARV therapy undergone by the HIV/AIDS patients hospitalized in a teaching hospital in Yogyakarta. Descriptive non-experimental design was used for the study. The data were obtained restrospectively from medical records of 71 patients who met the inclusion and exclusion criteria. The data were analyzed descriptively. The research findings indicated that, of the first-line ARV therapy, zidovudine+lamivudine+nevirapine (AZT+3TC+NVP) was mostly used (61.97%). It was found that all of the ARV types used were in accordance with the National Therapy Anteritroviral Guidelines (2007) from Health Ministry Department, Indonesia. As observed further, 61 (92.80%), 40 (85.000%), and 20 (85.00%) patients had their CD4 increased; 66 (72.72%), 44 (75.00%), 24 (79.17%) had gained weight; and 71 (100%), 55 (100%), and 31 (96.77%) had survived the disease after 6,12 and 24 months undergoing ARV therapy, However, the increase in CD4 after six-month therapy was not always attended by the increased in weight. To conclude, this phenomenon indicated good immune and clinical responses.

---

Availability

Detail Information

Series Title

-

Call Number

Majalah Farmasi Indonesia:22(3)2011:212-222

Publisher

Yogyakarta : Fakultas Farmasi UGM., 2011

Collation

10p.

Language

ISBN/ISSN

0126-1037

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

HIV
ANTIRETROVIRAL AGENTS

Specific Detail Info

-

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment